The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nanomedicine

• Publication date

  2010-12-03

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.2217/nnm.10.113PMID 21128723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect.

  2011cited by this paper
• A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction

  2011cited by this paper
• Non-viral nanosystems for systemic siRNA delivery.

  2010cited by this paper
• Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer

  2010cited by this paper
• The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.

  2010cited by this paper
• Targeting nanoparticles to cancer.

  2010cited by this paper
• Caveolae and cancer.

  2010cited by this paper
• Development of a highly stable and targetable nanoliposomal formulation of topotecan.

  2010cited by this paper
• Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.

  2010cited by this paper
• Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.

  2010cited by this paper
• Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes.

  2010cited by this paper
• Targeting of drugs and nanoparticles to tumors

  2010cited by this paper
• Novel drug delivery systems for sustained and targeted delivery of anti- cancer drugs: current status and future prospects.

  2010cited by this paper
• Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro.

  2010cited by this paper
• Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.

  2010cited by this paper
• Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles

  2009cited by this paper
• PEGylated PLGA nanoparticles for the improved delivery of doxorubicin.

  2009cited by this paper
• Comparison of the PLA-mPEG and mPEG-PLA-mPEG copolymers nanoparticles on the plasma protein adsorption and in vivo biodistribution

  2009cited by this paper
• Advances of cancer therapy by nanotechnology.

  2009cited by this paper
• Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies

  2009cited by this paper
• Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts

  2009cited by this paper
• Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan.

  2009cited by this paper
• Nanoparticles in cellular drug delivery.

  2009cited by this paper
• In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles.

  2009cited by this paper
• Antibody-conjugated nanoparticles for biomedical applications

  2009cited by this paper
• Nanoparticle-based targeted drug delivery.

  2009cited by this paper
• Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles

  2009cited by this paper
• Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

  2009cited by this paper
• Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

  2009cited by this paper
• Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.

  2009cited by this paper
• Phase II Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients with Advanced Pancreatic Cancer

  2009cited by this paper
• Synthesis and pH-dependent micellization of diblock copolymer mixtures.

  2009cited by this paper
• Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.

  2009cited by this paper
• Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids

  2009cited by this paper
• Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin

  2009cited by this paper
• In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.

  2009cited by this paper
• Tissue-penetrating delivery of compounds and nanoparticles into tumors.

  2009cited by this paper
• Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.

  2009cited by this paper
• Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.

  2009cited by this paper
• Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.

  2009cited by this paper
• Pharmacokinetic Study of Pegylated Liposomal CKD‐602 (S‐CKD602) in Patients With Advanced Malignancies

  2009cited by this paper
• Active targeting schemes for nanoparticle systems in cancer therapeutics.

  2008cited by this paper
• Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.

  2008cited by this paper
• Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery.

  2008cited by this paper
• Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.

  2008cited by this paper
• Protein nanoparticles as drug carriers in clinical medicine.

  2008cited by this paper
• Long circulating PEGylated poly(d,l-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors

  2008cited by this paper
• Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclines.

  2008cited by this paper
• Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.

  2008cited by this paper
• Does a targeting ligand influence nanoparticle tumor localization or uptake?

  2008cited by this paper
• Polymers and nanoparticles: intelligent tools for intracellular targeting?

  2008cited by this paper
• New frontiers in nanotechnology for cancer treatment.

  2008cited by this paper
• Particle size-dependent triggering of accelerated blood clearance phenomenon.

  2008cited by this paper
• The year's new drugs and biologics--2007.

  2008cited by this paper
• Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal Doxorubicin.

  2008cited by this paper
• Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

  2008cited by this paper
• Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.

  2007cited by this paper
• Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.

  2007cited by this paper
• STEALTH liposomal CKD-602, a topoisomerase I inhibitor, improves the therapeutic index in human tumor xenograft models.

  2007cited by this paper
• Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.

  2007cited by this paper
• Nanocarriers as an emerging platform for cancer therapy.

  2007cited by this paper
• Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.

  2007cited by this paper
• Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice

  2007cited by this paper
• The year's new drugs and biologics--2006.

  2007cited by this paper
• Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

  2007cited by this paper
• Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation.

  2007cited by this paper
• Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells

  2007cited by this paper
• Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

  2007cited by this paper
• New ways in RGD-peptide mediated drug targeting to angiogenic endothelium : On the nature of drugs, linkers, and carriers.

  2007cited by this paper
• A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

  2007cited by this paper
• 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.

  2007cited by this paper
• Functional amphiphilic and biodegradable copolymers for intravenous vectorisation

  2007cited by this paper
• Active targeting of brain tumors using nanocarriers.

  2007cited by this paper
• Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.

  2007cited by this paper
• In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy.

  2007cited by this paper
• Preparation and Characterization of Paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibody.

  2007cited by this paper
• Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery

  2007cited by this paper
• Nanomedicine: industry-wise research.

  2007cited by this paper
• Partition identities and Ramanujan's modular equations

  2007cited by this paper
• Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells.

  2007cited by this paper
• Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells

  2007cited by this paper
• Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts

  2007cited by this paper
• Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.

  2007cited by this paper
• ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics.

  2007cited by this paper
• Nanocarriers as an emerging platform for cancer therapy

  2007cited by this paper
• Long Circulating Poly(Ethylene Glycol)-Decorated Lipid Nanocapsules Deliver Docetaxel to Solid Tumors

  2006cited by this paper
• Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

  2006cited by this paper
• Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.

  2006cited by this paper
• Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

  2006cited by this paper
• Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.

  2006cited by this paper
• Polymer conjugates as anticancer nanomedicines

  2006cited by this paper
• Cancer of the gastroesophageal junction: Current therapy options

  2006cited by this paper
• Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.

  2006cited by this paper
• Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes.

  2006cited by this paper
• Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

  2006cited by this paper
• Pegylated Nanocapsules Produced by an Organic Solvent-Free Method: Evaluation of their Stealth Properties

  2006cited by this paper
• Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.

  2006cited by this paper
• Parameters influencing the stealthiness of colloidal drug delivery systems.

  2006cited by this paper
• A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization.

  2005cited by this paper
• Long-Circulating Polymeric Nanovectors for Tumor-Selective Gene Delivery

  2005cited by this paper

• Recent advances in lipid nanoparticles for cancer vaccine delivery: Challenges and future perspectives

  2026cites this paper
• Harnessing the Human Microbiome and its Impact on Immuno-Oncology and Nanotechnology for Next-Generation Cancer Therapies.

  2025cites this paper
• Tumor targeted radionuclide-nanomedicine for clinical translation: From carrier innovation to precision therapy.

  2025cites this paper
• Advancing Epigenetic Combination Therapy in Oncology: Multifunctional Nano-Drug Delivery Systems for Synergistic Efficacy and Precision Modulation

  2025cites this paper
• Deciphering the Impact of Hyaluronic Acid Grafting Density and Molecular Weight on Paclitaxel Liposome in CD-44 Receptor Targeting

  2025cites this paper
• Advances in Targeted Engineered Nanoparticle-Based Therapeutics for Respiratory Diseases: Current Insights and Future Perspectives

  2025cites this paper
• Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications

  2024cites this paper
• pH-Sensitive Fluorescent Probe in Nanogel Particles as Theragnostic Agent for Imaging and Elimination of Latent Bacterial Cells Residing Inside Macrophages

  2024cites this paper
• PLGA nanocapsules as a delivery system for a recombinant LRP‐based therapeutic

  2024cites this paper
• Characteristics and Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers

  2024cites this paper
• Mitochondrial‐Targeted Copper Delivery for Cuproptosis‐Based Synergistic Cancer Therapy

  2024cites this paper
• Polymeric Nanostructures Revolutionizing Cervical Cancer: Diagnostics, Therapeutics, and Theranostics

  2024cites this paper
• Targeted Polymeric Micelles System, Designed to Carry a Combined Cargo of L-Asparaginase and Doxorubicin, Shows Vast Improvement in Cytotoxic Efficacy

  2024cites this paper
• Imaging-guided precision hyperthermia with magnetic nanoparticles

  2024cites this paper
• Lipossomas como veículos inovadores em terapias medicamentosas: otimização de sistemas de entrega de fármacos

  2024cites this paper
• A review on Stimuli-pH responsive liposomal formulation in cancer therapy

  2023cites this paper
• Recent Progress and Challenges in Clinical Translation of Nanomedicines in Diagnosis and Treatment of Lung Cancer.

  2023cites this paper
• Thermal-triggered loading and GSH-responsive releasing property of HBc particles for drug delivery.

  2023cites this paper
• Administration-dependant efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma

  2023cites this paper
• Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials

  2022cites this paper
• RNAi-based therapeutics and tumor targeted delivery in cancer.

  2022cites this paper
• Impact of RAFT chain transfer agents on the polymeric shell density of magneto-fluorescent nanoparticles and their cellular uptake.

  2022cites this paper
• Nanotechnology for cancer theranostics

  2022cites this paper
• Advances in Lung Cancer Treatment Using Nanomedicines

  2022cites this paper
• Recent advances on drug delivery nanoplatforms for the treatment of autoimmune inflammatory diseases

  2022cites this paper
• Biofate and cellular interactions of lipid nanoparticles

  2022cites this paper
• Nanoparticle-based strategies to target HIV-infected cells.

  2022cites this paper
• Nanodrugs against cancer: biological considerations in its redesign

  2022cites this paper
• Multifunctional 99mTc-5-azacitidine gold nanoparticles: Formulation, in vitro cytotoxicity, radiosynthesis and in vivo pharmacokinetic study.

  2022cites this paper
• One-for-All Phototheranostic Agent Based on Aggregation-Induced Emission Characteristics for Multimodal Imaging-Guided Synergistic Photodynamic/Photothermal Cancer Therapy.

  2021cites this paper
• Optimizing Comprehensive Performance of Aggregation‐Induced Emission Nanoparticles through Molecular Packing Modulation for Multimodal Image‐Guided Synergistic Phototherapy

  2021cites this paper
• Photothermal and Enhanced Photocatalytic Therapies Conduce to Synergistic Anticancer Phototherapy with Biodegradable Titanium Diselenide Nanosheets.

  2021cites this paper
• Mixed-charge modification as a robust method to realize the antiviral ability of gold nanoparticles in a high protein environment.

  2021cites this paper
• Metallic nanoparticles as drug delivery system for the treatment of cancer

  2021cites this paper
• Magnetically responsive delivery into tumor environment

  2021cites this paper
• Ligands used for tumor targeting

  2021cites this paper
• Synthetic copolymer conjugates of docetaxel and in vitro assessment of anticancer efficacy

  2020cites this paper
• Two-dimensional silicene composite nanosheets enable exogenous/endogenous-responsive and synergistic hyperthermia-augmented catalytic tumor theranostics.

  2020cites this paper
• Nanoparticles for targeted cancer radiotherapy

  2020cites this paper
• Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies.

  2020cites this paper
• The Combination of Morphology and Surface Chemistry Defines the Biological Identity of Nanocarriers in Human Blood

  2020cites this paper
• Redox responsive nanoparticle encapsulating black phosphorus quantum dots for cancer theranostics

  2020cites this paper
• Recent advances in targeted nanomedicine as promising antitumor therapeutics.

  2020cites this paper
• Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells.

  2020cites this paper
• Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer

  2020cites this paper
• LIPOSSOMAS DE LONGA-CIRCULAÇÃO COMO ESTRATÉGIA PROMISSORA PARA O TRANSPORTE E BIODISPONIBILIZAÇÃO DE FÁRMACOS NO TRATAMENTO DO CÂNCER

  2020cites this paper
• Natural Hydrogels Applied in Photodynamic Therapy.

  2020cites this paper
• The Effect of Ligand Mobility on the Cellular Interaction of Multivalent Nanoparticles.

  2020cites this paper
• Nanomedicine advances in cancer therapy

  2020cites this paper
• Engineering the drug carrier biointerface to overcome biological barriers to drug delivery.

  2020cites this paper
• Vascular Nanomedicine: Current Status, Opportunities, and Challenges

  2019cites this paper
• A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.

  2019cites this paper
• Nanotoxicology: Developing a Responsible Technology

  2019cites this paper
• Particle toxicology and health - where are we?

  2019cites this paper
• Recent advances in the targeting of systemically administered non-viral gene delivery systems

  2019cites this paper
• A pH-Responsive Multifunctional Nanocarrier in the Application of Chemo-Photodynamic Therapy

  2019cites this paper
• Sorafenib encapsulated in nanocarrier functionalized with glypican-3 specific peptide for targeted therapy of hepatocellular carcinoma.

  2019cites this paper
• Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and in vivo biodistribution improvements

  2019cites this paper
• EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma

  2019cites this paper
• PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution

  2019cites this paper
• Gold Nanoparticle Aggregates Functionalized with Cyclic RGD Peptides for Targeting and Imaging of Colorectal Cancer Cells

  2019cites this paper
• PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution

  2019cites this paper
• The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment.

  2019cites this paper
• Effect of Hydrophobicity on Nano-Bio Interactions of Zwitterionic Luminescent Gold Nanoparticles at the Cellular Level.

  2018cites this paper
• Development of Dual Enzyme and Oxidation-responsive Drug Delivery Systems

  2018cites this paper
• The Hippo pathway as a drug target in gastric cancer.

  2018cites this paper
• Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlich's carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil.

  2018cites this paper
• Enzyme-Linked Immunosorbent Assay to Quantify Targeting Molecules on Nanoparticles.

  2018cites this paper
• Chemical stability, mass loss and hydrolysis mechanism of sterile and non-sterile lipid-core nanocapsules: The influence of the molar mass of the polymer wall

  2018cites this paper
• Sulforaphane-conjugated selenium nanoparticles: towards a synergistic anticancer effect

  2018cites this paper
• Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution

  2018cites this paper
• Reassessment of long circulation via monitoring of integral polymeric nanoparticles justifies a more accurate understanding.

  2018cites this paper
• In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.

  2017cites this paper
• Supercritical CO2-Assisted Spray Drying of Strawberry-Like Gold-Coated Magnetite Nanocomposites in Chitosan Powders for Inhalation

  2017cites this paper
• Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment

  2017cites this paper
• Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems

  2017cites this paper
• Lipid nanocapsules formulation and cellular activities evaluation of a promising anticancer agent: EAPB0503

  2017cites this paper
• Noninvasive photothermal cancer therapy nanoplatforms via integrating nanomaterials and functional polymers.

  2017cites this paper
• Cytotoxicological pathways induced after nanoparticle exposure: studies of oxidative stress at the 'nano-bio' interface.

  2017cites this paper
• Targeted and theranostic applications for nanotechnologies in medicine

  2017cites this paper
• Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance.

  2017cites this paper
• Nanosized drug delivery systems as radiopharmaceuticals

  2017cites this paper
• Nanotubes de titanate comme nanovecteurs polyvalents : radiosensibilisants du cancer de la prostate et sondes pour l'imagerie nucléaire

  2017cites this paper
• Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization

  2017cites this paper
• Polymeric Nanoparticles for Cancer Photodynamic Therapy.

  2016cites this paper
• Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy.

  2016cites this paper
• Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells.

  2016cites this paper
• Polymer Nanoparticles for Cancer Photodynamic Therapy Combined with Nitric Oxide Photorelease and Chemotherapy

  2016cites this paper
• EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery.

  2016cites this paper
• Cardiovascular Nanomedicine: Materials and Technologies

  2016cites this paper
• Synergistic nanomedicine by combined gene and photothermal therapy.

  2016cites this paper
• Development of multifunctional composite aerosols for lung cancer therapy

  2016cites this paper
• Nanomaterials in Pharmacology

  2016cites this paper
• Biodegradable black phosphorus-based nanospheres for in vivo photothermal cancer therapy

  2016cites this paper
• Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy.

  2016cites this paper
• Disulfide-bridged cleavable PEGylation in polymeric nanomedicine for controlled therapeutic delivery.

  2015cites this paper
• Multifunctional polymer-capped mesoporous silica nanoparticles for pH-responsive targeted drug delivery.

  2015cites this paper
• Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.

  2015cites this paper
• Zwitterionic polymeric micelles that undergo a pH-triggered positive charge for enhanced cellular uptake

  2015cites this paper
• Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer.

  2015cites this paper